Drug Detail

Drug Name XL147
Trade Name
Synonyms SAR245408|Pilaralisib
Drug Descriptions

Pilaralisib (XL147) is an inhibitor of all class I PI3Ks, thereby blocking activation of the PI3K signaling pathway and potentially resulting in antitumor activity including inhibition of cell proliferation, cell invasion, and tumor growth (PMID: 25637314).

DrugClasses PI3K Inhibitor (Pan) 34

Filtering

  • Case insensitive filtering will display rows where any text in any cell matches the filter term
  • Simple literal full or partial string matches
  • Separate multiple filter terms with a spaces, order doesn't matter (a b c and c b a are equivalent )
  • Filtering will only apply to rows that are already loaded on the page, filtering has no impact on query parameters
  • Use quotes to match a longer phrase which contains spaces "mtor c1483f"

Sorting

  • Generally, the default sort order for tables is set to be first column ascending, however, specific tables may set a different default sort order.
  • Click on any column header arrows to sort by that column
  • Hold down the Shift key and click multiple columns to sort by more than one column, be sure to set ascending or descending order for a given column, before moving on to the next column.

Therapy Name Drugs Efficacy Evidence Clinical Trials
Carboplatin + Paclitaxel + XL147 Carboplatin Paclitaxel XL147 0 0
Carboplatin + XL147 Carboplatin XL147 0 0
Paclitaxel + XL147 Paclitaxel XL147 1 0
SAR245409 + XL147 SAR245409 XL147 0 0
Seribantumab + XL147 Seribantumab XL147 1 0
Trastuzumab + XL147 Trastuzumab XL147 1 0
XL147 XL147 15 1


Additional content available in CKB BOOST